A test for the optineurin gene will be available to ophthalmologists soon - possibly this year and certainly by 2003, said S. Kumar Chandrasekaran, PhD, CEO of InSite Vision, Alameda, CA.
Related Content:
Myze launches for platform to engage 1 million dry eye patients by 2025: How Do Your Eyes Feel?
Orbis in-person training taking flight once again
EP. 2: EyeCon 2022: Location, location, location and bring the family
